Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 20, 2021, SpringWorks Therapeutics, Inc. (the "Company") held its annual meeting of stockholders to consider and vote on the proposals set forth below each of which is described in greater detail in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 15, 2021. The final voting results are set forth below.

Proposal 1 - Election of Directors

The stockholders elected each of the two persons named below to serve as a Class II director of the Company for a three-year term that expires at the Company's annual meeting of stockholders in 2024 and until his or her successor has been duly elected and qualified, subject to his or her earlier death, resignation or removal. The results of such vote were as follows:





                                                         Abstentions/
Director Name                   Votes For    Withheld     Non-Votes
Freda Lewis-Hall, M.D., DFAPA   32,231,274   7,661,807    2,313,268
Jeffrey Schwartz, M.B.A.        30,915,497   8,977,584    2,313,268

Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm

The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. The results of such vote were as follows:





Votes For    Votes Against   Abstentions
42,206,200        123            26

Proposal 3 - Non-Binding Advisory Vote on Executive Compensation

The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the annual meeting of stockholders. The results of such vote were as follows:





                             Abstentions/
Votes For    Votes Against    Non-Votes
37,049,687     2,829,187      2,327,475

Proposal 4 - Non-Binding Advisory Vote on the Frequency of Solicitation of Advisory Stockholder Approval of Executive Compensation

The stockholders approved, on a non-binding advisory basis, to set the frequency of soliciting advisory stockholder approval of the compensation of the Company's named executive officers, to every 1 year. The results of such vote were as follows:





  1 Year     2 Years   3 Years   Non-Votes
39,827,418    2,818    44,400    2,313,268

© Edgar Online, source Glimpses